Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wade Thompson

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Canadian Family Physician Medecin De Famille Canadien|January 24, 2018
Lise M Bjerre, Barbara Farrell, Matthew Hogel, et al.
Canadian Family Physician Medecin De Famille Canadien|January 24, 2018
Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: Evidence-based clinical practice guidelineLise M Bjerre, Barbara Farrell, Matthew Hogel, et al.
Journal of the American Geriatrics Society|April 18, 2023
Rates of overtreatment and deprescribing of antihyperglycemics among long-term care residents in British ColumbiaJeffrey Pan, Aaron Tejani, Alixandra Logan, et al.
Age and Ageing|June 11, 2025
Association between hypoglycaemic drug de-intensification, mortality and hospital admission in older adults with type 2 diabetes: a cohort study emulating a target trialAntoine Christiaens, Alexis Cochard, Florence Tubach, et al.
CMAJ Open|February 28, 2023
Prescribing, deprescribing and potential adverse effects of proton pump inhibitors in older patients with multimorbidity: an observational studyCarole E Aubert, Manuel R Blum, Viktoria Gastens, et al.
Research in Social & Administrative Pharmacy : RSAP|August 25, 2024
Development of the Guide to Disseminating Research (GuiDiR): A consolidated frameworkSion Scott, Bethany Atkins, Thomas D'Costa, et al.
BMJ Quality & Safety|May 24, 2024
What do clinical practice guidelines say about deprescribing? A scoping reviewAili Veronica Langford, Imaan Warriach, Aisling M McEvoy, et al.
CJC Open|September 2, 2025
Uptake of novel evidence-based therapies in patients with type 2 diabetes after a cardiovascular event: insights from CANHEARTWade Thompson, Brendan Wong, Atul Sivaswamy, et al.
Drugs & Aging|May 6, 2024
Measuring Quality of Life in Deprescribing Trials: A Scoping ReviewWade Thompson, Carina Lundby, Adam Bleik, et al.
JACC. Advances|July 25, 2025
Cholesterol Levels and Cardiovascular Outcomes Following Statin Initiation for Primary Prevention: A Cohort StudyWade Thompson, Irene Jeong, Shalane Basque, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Canadian Family Physician Medecin De Famille Canadien|January 24, 2018
Lise M Bjerre, Barbara Farrell, Matthew Hogel, et al.
Canadian Family Physician Medecin De Famille Canadien|January 24, 2018
Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: Evidence-based clinical practice guidelineLise M Bjerre, Barbara Farrell, Matthew Hogel, et al.
Journal of the American Geriatrics Society|April 18, 2023
Rates of overtreatment and deprescribing of antihyperglycemics among long-term care residents in British ColumbiaJeffrey Pan, Aaron Tejani, Alixandra Logan, et al.
Age and Ageing|June 11, 2025
Association between hypoglycaemic drug de-intensification, mortality and hospital admission in older adults with type 2 diabetes: a cohort study emulating a target trialAntoine Christiaens, Alexis Cochard, Florence Tubach, et al.
CMAJ Open|February 28, 2023
Prescribing, deprescribing and potential adverse effects of proton pump inhibitors in older patients with multimorbidity: an observational studyCarole E Aubert, Manuel R Blum, Viktoria Gastens, et al.
Research in Social & Administrative Pharmacy : RSAP|August 25, 2024
Development of the Guide to Disseminating Research (GuiDiR): A consolidated frameworkSion Scott, Bethany Atkins, Thomas D'Costa, et al.
BMJ Quality & Safety|May 24, 2024
What do clinical practice guidelines say about deprescribing? A scoping reviewAili Veronica Langford, Imaan Warriach, Aisling M McEvoy, et al.
CJC Open|September 2, 2025
Uptake of novel evidence-based therapies in patients with type 2 diabetes after a cardiovascular event: insights from CANHEARTWade Thompson, Brendan Wong, Atul Sivaswamy, et al.
Drugs & Aging|May 6, 2024
Measuring Quality of Life in Deprescribing Trials: A Scoping ReviewWade Thompson, Carina Lundby, Adam Bleik, et al.
JACC. Advances|July 25, 2025
Cholesterol Levels and Cardiovascular Outcomes Following Statin Initiation for Primary Prevention: A Cohort StudyWade Thompson, Irene Jeong, Shalane Basque, et al.
Pageof 11